The Safety of Pharmacopuncture on Musculoskeletal Patients
NCT ID: NCT05318859
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2022-04-27
2025-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Pharmacopuncture for Chronic Neck Pain
NCT04035018
Effectiveness of Dry Needling in Patients With Chronic Nonspecific Low Back Pain
NCT05100381
The Effectiveness of Pharmacopuncture on Acute Tension Headache
NCT05549765
Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Inpatients With Sciatica Due to Lumbar Intervertebral Disc Herniation
NCT03750591
The Efficacy and Safety of Lumbar MSAT on Acute Low Back Pain
NCT04956458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacopuncture
Registry (observational study)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received pharmacopuncture treatment during hospitalization
* Patients who are 19 years of age or older and less than 70 years old
* Patients who agreed to participate in the clinical study and voluntarily given written informed consent
Exclusion Criteria
* Patients for whom the researchers judge participation in the clinical study to be difficult
19 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jaseng Medical Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
In-Hyuk Ha, KMD
Hospital director, Research director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
In-Hyuk Ha, Ph.D.
Role: STUDY_DIRECTOR
Jaseng Medical Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, Daejeon, South Korea
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, South Korea
Haeundae Jaseng Hospital of Korean Medicine
Busan, , South Korea
Kyung Hee University Korean Medicine Hospital
Seoul, , South Korea
Kyung Hee University Hospital at Gangdong
Seoul, , South Korea
Dongguk University Bundang Oriental Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-CT-2021-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.